RILEXINE 200 MG/G ORAL PASTE
RILEXINE 200 MG/G ORAL PASTE
Not authorised
- Cefalexin
Product identification
Medicine name:
RILEXINE 200 MG/G ORAL PASTE
Active substance:
- Cefalexin
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Cefalexin200.00/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Oral paste
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01D
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Revoked
Authorised in:
-
Poland
Package description:
- Box with one aluminium sachet containing one graduated syringe of 21 g of oral paste (7 doses): each dose can treat 20 kg
- Box with one aluminium sachet containing one graduated syringe of 10.5 g of oral paste (7 doses): each dose can treat 10 kg
- Box with one aluminium sachet containing one graduated syringe of 4.2 g of oral paste (14 doses): each dose can treat 2 kg
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Virbac
Responsible authority:
- Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
- 1691
Date of authorisation status change:
Reference member state:
-
Italy
Procedure number:
- IT/V/0119/001
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet